NCT01654458已完成不适用
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 398
- 试验地点
- 10
- 主要终点
- Psychosexual distress, as measured by the Revised Female Sexual Distress Scale (FSDS-R).
研究概览
简要总结
There is a high prevalence of sexual and body image problems among women treated for gynecologic cancer, which can lead to considerable distress. Given the sensitive and highly personal nature of these problems, women are often reluctant to speak to their doctors about these concerns and have few resources for support and information. The research team will conduct a prospective randomized controlled trail (RCT) to test the benefits of "GyneGals," a 12-week online (i.e. Internet-based) support group intervention for women who are sexually distressed due to gynecologic cancer and its treatment.
The primary aim of this study is to determine whether a professionally-facilitated, information-rich, online support group is beneficial for women who are sexually distressed due to gynecologic cancer and the side effects of treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Received surgical, radiation or chemotherapy treatments for any gynecologic cancer
- •Not receiving active treatment
- •Currently disease-free for a minimum of 3 months
- •No more than 5 years post-diagnosis
- •Distressed due to psychosexual concerns related to cancer
- •Willing to discuss psychosexual concerns
- •18 years or older
- •Has access to a computer and the Internet
- •Speaks, reads, and writes in English
- •Provides informed consent
排除标准
- •Acutely suicidal (i.e., actively suicidal within the previous 3 months)
- •Has a major psychiatric illness
结局指标
主要结局
Psychosexual distress, as measured by the Revised Female Sexual Distress Scale (FSDS-R).
时间窗: 9 months
13-item self-report scale that measures sexually-related distress in women.
次要结局
- Body image, as measured by the Sexual Adjustment and Body Image Scale - Gynecologic Cancer (SABIS-G).(9 months (at months 1, 5, and 9))
- Depression and anxiety symptoms, as measured by the Hospital Anxiety and Depression Scale (HADS).(9 months (at months 1, 5, and 9))
- Relationship satisfaction, as measured by the Relationship Assessment Scale (RAS).(9 months (at months 1, 5, and 9))
- Perceived social support, as measured by MOS Social Support Survey (MOS-SS).(9 months (at months 1, 5, and 9))
- Sexual function, as measured by the Sexual Function Questionnaire (SFQ).(9 months (at months 1, 5, and 9))
研究者
研究点 (10)
Loading locations...
相似试验
已完成
不适用
The Impact of Mindful Compassion on Sexual Functioning Post Breast Cancer TreatmentSexual FunctioningNCT06046716London Metropolitan University52
已完成
不适用
Evaluation of an Online Intervention for Female Sexual DysfunctionFemale Sexual DysfunctionNCT06237166Gaia AG252
已完成
不适用
A Mobile-App Training to Reduce Body Image Disorder Symptoms and Associated Features in Female University StudentsBody Image DisorderBody Dysmorphic DisordersEating DisordersNCT04103606University of Padova100
进行中（未招募）
不适用
Sexual Health and Rehabilitation Online (SHAREonline)Cancer SurvivorshipSexual Function DisturbancesNCT06458049Dana-Farber Cancer Institute84
已完成
2 期
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerOvarian SarcomaOvarian Stromal CancerStage I Uterine SarcomaStage I Vaginal CancerStage I Vulvar CancerStage IA Cervical CancerStage IA Endometrial CarcinomaStage IA Fallopian Tube CancerStage IA Ovarian Epithelial CancerStage IA Ovarian Germ Cell TumorStage IA Primary Peritoneal Cavity CancerStage IB Cervical CancerStage IB Endometrial CarcinomaStage IB Fallopian Tube CancerStage IB Ovarian Epithelial CancerStage IB Ovarian Germ Cell TumorStage IB Primary Peritoneal Cavity CancerStage IC Fallopian Tube CancerStage IC Ovarian Epithelial CancerStage IC Ovarian Germ Cell TumorStage IC Primary Peritoneal Cavity CancerStage II Endometrial CarcinomaStage II Gestational Trophoblastic TumorStage II Uterine SarcomaStage II Vaginal CancerStage II Vulvar CancerStage IIA Cervical CancerStage IIA Fallopian Tube CancerStage IIA Ovarian Epithelial CancerStage IIA Ovarian Germ Cell TumorStage IIA Primary Peritoneal Cavity CancerStage IIB Cervical CancerStage IIB Fallopian Tube CancerStage IIB Ovarian Epithelial CancerStage IIB Ovarian Germ Cell TumorStage IIB Primary Peritoneal Cavity CancerStage IIC Fallopian Tube CancerStage IIC Ovarian Epithelial CancerStage IIC Ovarian Germ Cell TumorStage IIC Primary Peritoneal Cavity CancerStage III Gestational Trophoblastic TumorStage III Uterine SarcomaStage III Vaginal CancerStage III Vulvar CancerStage IIIA Cervical CancerStage IIIA Endometrial CarcinomaStage IIIA Fallopian Tube CancerStage IIIA Ovarian Epithelial CancerStage IIIA Ovarian Germ Cell TumorStage IIIA Primary Peritoneal Cavity CancerStage IIIB Cervical CancerStage IIIB Endometrial CarcinomaStage IIIB Fallopian Tube CancerStage IIIB Ovarian Epithelial CancerStage IIIB Ovarian Germ Cell TumorStage IIIB Primary Peritoneal Cavity CancerStage IIIC Endometrial CarcinomaStage IIIC Fallopian Tube CancerStage IIIC Ovarian Epithelial CancerStage IIIC Ovarian Germ Cell TumorStage IIIC Primary Peritoneal Cavity CancerBreast CancerNCT01764802Ohio State University Comprehensive Cancer Center100